Doctor of Philosophy in Pharmaceutical Economics and Policy

Prepare to assume a leadership role in pharmaceutical and healthcare economics or policy with the knowledge and expertise you build in this strategic program. This PhD program at the MCPHS Boston campus focuses on pharmaceutical and health economics as well as drug and health policy. It also provides you with training and experience in outcomes research, regulation, marketing, healthcare administration, pharmacy services research, and pharmacoepidemiology. When you graduate, you will be prepared for a career in many areas of this field, including the pharmaceutical, biotechnology, and medical device industries; healthcare; and government or academia. If accepted, you may start the program in either the fall or spring semester.

PharmD or an earned master’s degree or higher degree in a related area (e.g., economics, sociology, or statistics), or a professional degree in medicine, dentistry, nursing, public health, or healthcare administration from an accredited college or university. Students currently enrolled in the PEP Master of Science Thesis degree program may apply to the PhD program after they complete their MS program

TOEFL or IELTS, required of all applicants for whom English is not the primary spoken language. This test requirement may be waived on an individual basis for applicants who have attended all four years of high school in the United States or have an earned degree (bachelor’s or higher) from a U.S. college or university

Minimum grade point average (GPA) of 3.0

Non-lab-based Programs Language Proficiency: IELTS - 6.5; TOEFL iBT- 79; TOEFL ITP - 587; iTEP - 4.0; PTE Academic – 58; Duolingo - 105.

Lab-based Programs Language Proficiency: IELTS - 7.0; TOEFL iBT- 90; TOEFL ITP - 610; iTEP - 4.5; PTE Academic – 73; Duolingo - 115.

August 1: Fall start application deadline.

December 1: Spring start application deadline.